Form 4: Regentis Biomaterials Director Receives Stock Grant
Insider Transaction (Form 4)
Pini Ben-Elazar, a Director of Regentis Biomaterials Ltd., reported multiple transactions in common stock on July 9, 2026.
Summary
- Grant/award: acquired 24,826 Employee Stock Option (Right to Buy) on July 9, 2026; holds 24,826 after (Direct).
- Grant/award: acquired 8,313 Employee Stock Option (Right to Buy) on July 9, 2026; holds 8,313 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Pini Ben-Elazar — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Grant/award | Employee Stock Option (Right to Buy) | 24,826 | — | — | 24,826 |
| 2026-07-09 | Grant/award | Employee Stock Option (Right to Buy) | 8,313 | — | — | 8,313 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Grant/award (24,826 shares) |
| 2026-07-09 | Grant/award (8,313 shares) |
Keywords
insider transaction, Form 4, RGNT, REGENTIS BIOMATERIALS LTD., neutral, Pini Ben-Elazar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.